Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition-Reference-Cited by-同舟云学术

Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition

Published:2019-05 Issue:17 Volume:73 Page:2237-2239
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Andelfinger Gregor,Marquis Christopher,Raboisson Marie-Josée,Théoret Yves,Waldmüller Stephan,Wiegand Gesa,Gelb Bruce D.,Zenker Martin,Delrue Marie-Ange,Hofbeck Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry;Wilkinson;Am Heart J,2012

2. K-RasV14I recapitulates Noonan syndrome in mice;Hernandez-Porras;Proc Natl Acad Sci U S A,2014

3. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation;Wu;J Clin Invest,2011

4. Age-specific reference intervals for indexed left ventricular mass in children;Khoury;J Am Soc Echocardiography,2009

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics of congenital heart disease;Nadas' Pediatric Cardiology;2025

2. Cardiac Phenotype and Gene Mutations in RASopathies;Genes;2024-08-02

3. Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses;Med;2024-07

4. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01

5. Trametinib restores the central conducting lymphatic flow in a premature infant with Noonan syndrome;Clinical Case Reports;2024-07